Chemotherapy regimens immunotherapy adoptive. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor T-Lymphocytes, Cytotoxic Dendritic Cells T-Lymphocytes Lymphocytes, Tumor-Infiltrating CD8-Positive T-Lymphocytes Tumor Cells, Cultured Pollen Cytokine-Induced Killer Cells CD4-Positive T-Lymphocytes

Organisms2

Mice, Inbred C57BL Mice, Inbred BALB C

Diseases76

Lung Neoplasms Breast Neoplasms Neoplasms Lymphoma, Non-Hodgkin Neoplasm Recurrence, Local Neutropenia Neoplasm Metastasis Hodgkin Disease Nausea Vomiting Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Colorectal Neoplasms Testicular Neoplasms Adenocarcinoma Recurrence Leukopenia Neoplasms, Germ Cell and Embryonal Melanoma Brain Neoplasms Disease Progression Lymphoma Liver Neoplasms Bone Neoplasms Rhinitis, Allergic, Seasonal Thrombocytopenia Hematologic Diseases Lymphoma, Large B-Cell, Diffuse Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, B-Cell Carcinoma Peritoneal Neoplasms Stomach Neoplasms Osteosarcoma Lymphatic Metastasis Lymphoma, Follicular Leukemia, Myeloid, Acute Carcinoma, Squamous Cell Head and Neck Neoplasms Carcinoma, Small Cell Germinoma Melanoma, Experimental Mediastinal Neoplasms Fever Seminoma Central Nervous System Neoplasms Burkitt Lymphoma Sarcoma Mesothelioma Multiple Myeloma Retroperitoneal Neoplasms Colonic Neoplasms Leukemia Pancreatic Neoplasms Stomatitis Bone Marrow Diseases Biliary Tract Neoplasms Lymphoma, Mantle-Cell Urinary Bladder Neoplasms Neoplasm, Residual Sarcoma, Ewing Leukemia, Myeloid Neoplasms, Unknown Primary Neoplasms, Experimental Alopecia Glioblastoma Urologic Neoplasms Pleural Neoplasms Kidney Neoplasms Glioma Amenorrhea Rectal Neoplasms Carcinoma, Transitional Cell Hypersensitivity Neoplasms, Second Primary Medulloblastoma

Chemicals and Drugs80

Cyclophosphamide Cisplatin Doxorubicin Antineoplastic Agents Etoposide Vincristine Methotrexate Vinblastine Bleomycin Ifosfamide Taxoids Paclitaxel Deoxycytidine Anthracyclines Fluorouracil Carboplatin Organoplatinum Compounds Cancer Vaccines Cytarabine Antibodies, Monoclonal Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Antigens, Neoplasm Prednisone Lomustine Dacarbazine Antineoplastic Agents, Phytogenic Granulocyte Colony-Stimulating Factor Camptothecin Epirubicin Antibodies, Monoclonal, Humanized Mitoxantrone Procarbazine Leucovorin Carmustine Antibodies, Monoclonal, Murine-Derived Antiemetics Bridged Compounds Antibiotics, Antineoplastic Melphalan Mitomycin Mesna Platinum Compounds Tumor Markers, Biological Receptor, erbB-2 Dexamethasone Tegafur Prednisolone Allergens Interleukin-2 Vindesine Thiotepa Daunorubicin Altretamine Recombinant Proteins Prochlorperazine Oxonic Acid Angiogenesis Inhibitors Fluoxymesterone Topotecan Quinazolines Mechlorethamine Platinum Idarubicin Asparaginase HLA-A2 Antigen BCG Vaccine Vidarabine Bee Venoms Antibodies, Neoplasm Mitomycins Drug Combinations Adjuvants, Immunologic Immunoglobulin E Interferon-gamma Neoplasm Proteins Antigens, Plant Alzheimer Vaccines Antineoplastic Agents, Hormonal Epitopes, T-Lymphocyte

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Immunotherapy Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Immunotherapy, Adoptive Treatment Outcome Combined Modality Therapy Immunotherapy, Active Drug Administration Schedule Disease-Free Survival Desensitization, Immunologic Survival Analysis Survival Rate Neoplasm Staging Prognosis Salvage Therapy Neoadjuvant Therapy Clinical Trials as Topic Infusions, Intravenous Follow-Up Studies Transplantation, Autologous Remission Induction Hematopoietic Stem Cell Transplantation Prospective Studies Administration, Sublingual Radiotherapy, Adjuvant Randomized Controlled Trials as Topic Kaplan-Meier Estimate Sublingual Immunotherapy Clinical Trials, Phase III as Topic Drug Evaluation Retrospective Studies Actuarial Analysis Administration, Oral Radiotherapy Drug Therapy Clinical Trials, Phase II as Topic Pilot Projects Induction Chemotherapy Drug Therapy, Combination Radiotherapy Dosage Bone Marrow Transplantation Palliative Care Multivariate Analysis Feasibility Studies Cranial Irradiation Treatment Failure Hematopoietic Stem Cell Mobilization Melanoma, Experimental Maximum Tolerated Dose Leukapheresis Infusions, Intra-Arterial Immunization, Passive Proportional Hazards Models Stem Cell Transplantation Lymphocyte Activation Risk Factors Random Allocation Chemotherapy, Cancer, Regional Perfusion Chemoradiotherapy Immunohistochemistry Drug Screening Assays, Antitumor Radioimmunotherapy Transplantation, Homologous Molecular Targeted Therapy Neoplasms, Experimental Flow Cytometry Neoplasm Transplantation Double-Blind Method Transplantation Conditioning Xenograft Model Antitumor Assays Injections, Subcutaneous Blood Cell Count Peripheral Blood Stem Cell Transplantation Injections, Intravenous

Phenomena and Processes10

Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Maximum Tolerated Dose Cytotoxicity, Immunologic Lymphocyte Activation Drug Synergism Tumor Escape Apoptosis Blood Cell Count

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science2

Survival Rate Informatics

Health Care23

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Clinical Trials as Topic Follow-Up Studies Prospective Studies Randomized Controlled Trials as Topic Kaplan-Meier Estimate Clinical Trials, Phase III as Topic Retrospective Studies Actuarial Analysis Clinical Trials, Phase II as Topic Pilot Projects Palliative Care Multivariate Analysis Feasibility Studies Treatment Failure Proportional Hazards Models Risk Factors Random Allocation Age Factors Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Immunotherapy Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Cyclophosphamide Immunotherapy, Adoptive Treatment Outcome Cisplatin Doxorubicin Combined Modality Therapy Antineoplastic Agents Etoposide Immunotherapy, Active Drug Administration Schedule Disease-Free Survival Desensitization, Immunologic Survival Analysis Vincristine Survival Rate Methotrexate Vinblastine Bleomycin Lung Neoplasms Ifosfamide Breast Neoplasms Neoplasm Staging Taxoids Paclitaxel Prognosis Neoplasms Salvage Therapy Deoxycytidine Anthracyclines Lymphoma, Non-Hodgkin Fluorouracil Neoadjuvant Therapy Carboplatin Organoplatinum Compounds Neoplasm Recurrence, Local Neutropenia Cancer Vaccines Cytarabine Neoplasm Metastasis Hodgkin Disease Antibodies, Monoclonal Clinical Trials as Topic Antimetabolites, Antineoplastic Infusions, Intravenous Antineoplastic Agents, Alkylating Nausea Drug Resistance, Neoplasm Follow-Up Studies Antigens, Neoplasm Prednisone Transplantation, Autologous Lomustine Vomiting Carcinoma, Non-Small-Cell Lung Dacarbazine Antineoplastic Agents, Phytogenic Granulocyte Colony-Stimulating Factor Camptothecin Time Factors Dose-Response Relationship, Drug Ovarian Neoplasms Epirubicin Colorectal Neoplasms Antibodies, Monoclonal, Humanized Remission Induction Testicular Neoplasms Adenocarcinoma Mitoxantrone Recurrence Procarbazine Leucovorin Hematopoietic Stem Cell Transplantation Prospective Studies Leukopenia Administration, Sublingual Carmustine Neoplasms, Germ Cell and Embryonal Radiotherapy, Adjuvant Melanoma Antibodies, Monoclonal, Murine-Derived Brain Neoplasms Cell Line, Tumor Disease Progression Antiemetics Bridged Compounds Randomized Controlled Trials as Topic Antibiotics, Antineoplastic Kaplan-Meier Estimate Sublingual Immunotherapy Clinical Trials, Phase III as Topic Lymphoma Melphalan Drug Evaluation Mitomycin Liver Neoplasms Mesna Platinum Compounds

No FAQ available that match "chemotherapy regimens immunotherapy adoptive"